Search Results 421-430 of 18201 for crohn's disease

  1. A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) - Mayo Clinic

    A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) ... and stage of disease, and previous ...

  2. Christina Y. Ha, M.D. - Mayo Clinic Faculty Profiles

    Ha, M.D., specializes in the diagnosis and treatment of the inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis. Her IBD clinical care ...

  3. A Study To Evaluate The Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderate To Severe Crohn's Disease (MK-7240-008) - Mayo Clinic

    ... and safety of tulisokibart in participants with moderately to severely active Crohn's disease. ... and stage of disease, and previous treatments or health ...

  4. Digestive Diseases Clinical Trials - Medical Professionals

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  5. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease - Mayo Clinic

    ... Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  6. Adalimumab-adaz (subcutaneous route) - Mayo Clinic

    ... and older and for the treatment of Crohn's disease in children 6 years of age and older. However, safety and efficacy have not been established in children ...

  7. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

    Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease · Overview · Participation eligibility · Participating Mayo Clinic ...

  8. Examining HBV vaccine efficacy and durability in individuals with IBD and celiac disease - Mayo Clinic

    Individuals diagnosed with inflammatory bowel disease (IBD) or celiac disease (CD) are presumed to have a suboptimal humoral response to the hepatitis B virus ( ...

  9. Digestive Diseases Clinical Trials - Medical Professionals

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  10. A Study to Evaluate Posaconazole to Treat Genetically-defined Patients with Active Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. ... AND active symptoms of Crohn's disease ( ...